16:53:38 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:PCRX - PACIRA BIOSCIENCES INC - http://www.pacira.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PCRX - Q5.825.81·26.855.526.33+0.833.3304.67,7225,10225.34  26.37  25.3348.60  25.73516:20:00Apr 0215 min RT 2¢

Recent Trades - Last 10 of 5102
Time ETExPriceChangeVolume
16:20:00Q26.330.83321
16:13:44Q26.330.8316
16:02:05Q26.330.83101
16:01:38Q26.330.831,337
16:01:34Q26.330.83157
16:01:32Q26.330.83119
16:01:15Q26.330.8374
16:01:09Q26.330.831,056
16:00:05Q26.330.834,000
16:00:04Q26.330.832,694

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-02 08:00U:PCRXNews ReleasePacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
2024-03-13 07:00U:PCRXNews ReleasePacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
2024-03-06 08:00U:PCRXNews ReleasePacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
2024-02-29 08:00U:PCRXNews ReleasePacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
2024-02-22 08:00U:PCRXNews ReleasePacira to Report 2023 Financial Results on Thursday February 29, 2024
2024-02-15 08:36U:PCRXNews ReleasePacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
2024-02-07 08:00U:PCRXNews ReleasePacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
2024-02-01 10:45U:PCRXNews ReleaseG.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams
2024-01-04 17:01U:PCRXNews ReleasePacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
2024-01-03 08:00U:PCRXNews ReleasePacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-21 07:30U:PCRXNews ReleasePacira Appoints Frank D. Lee as Chief Executive Officer
2023-11-10 07:30U:PCRXNews ReleasePacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
2023-11-07 08:00U:PCRXNews ReleasePacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
2023-11-02 08:00U:PCRXNews ReleasePacira BioSciences Reports Third Quarter 2023 Financial Results
2023-10-26 08:00U:PCRXNews ReleasePacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
2023-10-12 08:00U:PCRXNews ReleaseAmerican Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
2023-10-10 08:00U:PCRXNews ReleasePacira BioSciences Appoints Four New Independent Directors to its Board of Directors
2023-10-02 08:00U:PCRXNews ReleaseAmerican Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
2023-09-26 16:30U:PCRXNews ReleasePacira BioSciences Announces Leadership Succession Plan
2023-09-06 08:00U:PCRXNews ReleasePacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference